ADC Therapeutics (NYSE: ADCT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.
There are no as such competitors for ADC Therapeutics.
The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by Morgan Stanley on Tuesday, May 10, 2022. The analyst firm set a price target for 17.00 expecting ADCT to rise to within 12 months (a possible 99.76% upside). 10 analyst firms have reported ratings in the last year.
The stock price for ADC Therapeutics (NYSE: ADCT) is $8.51 last updated July 1, 2022, 7:59 PM UTC.
There are no upcoming dividends for ADC Therapeutics.
ADC Therapeutics’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for ADC Therapeutics.
ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.